New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg - soft gelatin capsule - 20 mg - active: vinorelbine tartrate 27.7mg equivalent to vinorelbine 20 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide yellow macrogol 400 medium-chain triglycerides purified water   titanium dioxide - first line treatment of advanced non-small cell lung cancer (nsclc) as a single agent or in combination

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg - soft gelatin capsule - 30 mg - active: vinorelbine tartrate 41.55mg equivalent to vinorelbine 30 mg excipient: edible ink red ethanol gelatin glycerol   anidrisorb 85/70 85% phosal 53 mct iron oxide red macrogol 400 medium-chain triglycerides purified water   titanium dioxide - first line treatment of advanced non-small cell lung cancer (nsclc) as a single agent or in combination

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - vinorelbine tartrate 13.85 mg/ml equivalent to 10 mg/ml vinorelbine - solution for injection - 10 mg/ml - active: vinorelbine tartrate 13.85 mg/ml equivalent to 10 mg/ml vinorelbine excipient: water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - asparaginase 10000 [iu] - powder for injection - 10000 iu - active: asparaginase 10000 [iu] excipient: glucose monohydrate sodium chloride water for injection - erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. it may also be used in other neoplastic conditions where depletion of asparagines might be expected to have a useful effect. patients receiving treatment with l-asparaginase from escherichia coli, and who develop hypersensitivity to that enzyme may be able to continue treatment with erwinase as the enzymes are immunologically distinct.

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - ethinylestradiol 0.01mg - tablet - 0.01 mg - active: ethinylestradiol 0.01mg excipient: acacia alginic acid ethanol lactose monohydrate magnesium stearate potato starch water - postmenopausal symptoms due to oestrogen deficiency including prevention of postmenopausal osteoporosis. in women with an intact uterus the addition of a progestogen is essential

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - sodium tetradecyl sulfate 0.2%{relative} - solution for injection - 0.2 % - active: sodium tetradecyl sulfate 0.2%{relative} excipient: benzyl alcohol dibasic sodium phosphate dodecahydrate monobasic potassium phosphate sodium hydroxide water for injection - the treatment of minor venules and spider veins (venous flares) by injection sclerotherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - sodium tetradecyl sulfate 0.5%{relative} - solution for injection - 0.5 % - active: sodium tetradecyl sulfate 0.5%{relative} excipient: benzyl alcohol dibasic sodium phosphate monobasic potassium phosphate sodium hydroxide water for injection - the treatment of varicose veins and venous flares of the leg by injection sclerotherapy

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - sodium tetradecyl sulfate 1%{relative} - solution for injection - 1 % - active: sodium tetradecyl sulfate 1%{relative} excipient: benzyl alcohol dibasic sodium phosphate monobasic potassium phosphate sodium hydroxide water for injection - the treatment of varicose veins of the leg by injection sclerotherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand medical & scientific ltd - sodium tetradecyl sulfate 3%{relative} - solution for injection - 3 % - active: sodium tetradecyl sulfate 3%{relative} excipient: benzyl alcohol dibasic sodium phosphate monobasic potassium phosphate sodium hydroxide water for injection - the treatment of varicose veins of the leg by injection sclerotherapy.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - inactivated newcastle disease virus antigen - parenteral liquid/solution/suspension - inactivated newcastle disease virus antigen vaccine-viral active 0.0 eid/50 - immunotherapy - poultry - see label | chicken - newcastle disease